Wolanski K D, Whitaker D, Shilkin K B, Henderson D W
Western Australian Centre for Pathology & Medical Research, Queen Elizabeth II Medical Centre, Nedlands.
Cancer. 1998 Feb 1;82(3):583-90. doi: 10.1002/(sici)1097-0142(19980201)82:3<583::aid-cncr22>3.0.co;2-x.
The accurate diagnosis of pleural lesions obtained from small closed biopsy is difficult. As yet there is no single reliable test to distinguish between malignant and benign mesothelial tissue.
Immunostaining of epithelial membrane antigen (EMA) and the quantitation of silver stained nucleolar organizer regions (AgNORs) each were applied to benign and malignant histologic sections of pleural and peritoneal biopsies. The usefulness of these stains was tested both individually and in combination in the diagnosis of epithelial malignant mesothelioma.
One hundred and three of the 141 malignant lesions (73%) were immunoreactive for EMA but only 3 of the 73 benign lesions (4%) reacted equivocally, and none positively. The average count of AgNORs/cell in malignant lesions (n = 80) was elevated compared with benign cases (n = 26), but a significant overlap was exhibited in the AgNOR count and this form of analysis was considered to be of little value in distinguishing benign from malignant mesothelial processes. Much less overlap was observed when the average AgNOR area was measured. By using the maximum benign AgNOR area of 0.6677 microm2 as the upper threshold, 51 cases (63.8%) were identified as malignant; the test demonstrated 100% specificity and 63.8% sensitivity. By combining the EMA and AgNOR results, 76 of 80 of the malignant mesothelioma cases (95%) tested positive for at least 1 of the tests with no false-positive results identified.
This study confirms the usefulness of EMA in diagnosing malignant and benign mesothelial lesions, and demonstrates the enhanced diagnostic value of combining EMA immunoreaction with the average area of AgNOR per cell, thereby increasing sensitivity in the diagnosis of epithelial malignant mesothelioma.
通过小切口闭式活检获取的胸膜病变的准确诊断较为困难。目前尚无单一可靠的检测方法来区分恶性和良性间皮组织。
上皮膜抗原(EMA)免疫染色和银染核仁组成区(AgNORs)定量分析分别应用于胸膜和腹膜活检的良性和恶性组织学切片。分别单独及联合使用这些染色方法来检测其在诊断上皮性恶性间皮瘤中的效用。
141例恶性病变中有103例(73%)对EMA呈免疫反应,而73例良性病变中只有3例(4%)呈可疑反应,无阳性反应。恶性病变(n = 80)中AgNORs/细胞的平均计数高于良性病例(n = 26),但AgNOR计数存在显著重叠,这种分析形式在区分良性和恶性间皮病变方面价值不大。测量平均AgNOR面积时观察到的重叠要少得多。以最大良性AgNOR面积0.6677平方微米作为上限阈值,51例(63.8%)被判定为恶性;该检测方法特异性为100%,敏感性为63.8%。将EMA和AgNOR结果相结合,80例恶性间皮瘤病例中有76例(95%)至少一项检测呈阳性,未发现假阳性结果。
本研究证实了EMA在诊断恶性和良性间皮病变中的效用,并证明将EMA免疫反应与每个细胞的AgNOR平均面积相结合可提高诊断价值,从而提高上皮性恶性间皮瘤诊断的敏感性。